Detalhe da pesquisa
1.
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group.
Lancet Oncol
; 24(7): e293-e311, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414019
2.
Corneal Changes After Belantamab Mafodotin in Multiple Myeloma Patients.
Eye Contact Lens
; 47(6): 362-365, 2021 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306485
3.
Intravesicular Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation.
Ann Pharmacother
; 54(6): 547-553, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31876431
4.
Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assay.
Br J Haematol
; 173(6): 884-95, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27071340
5.
Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study.
Cancer
; 121(7): 1064-70, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25469920
6.
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy.
Blood Adv
; 8(1): 251-259, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855718
7.
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies.
Haematologica
; 98(11): 1753-61, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23935022
8.
Addressing the disparities: the approach to the African American patient with multiple myeloma.
Blood Cancer J
; 13(1): 189, 2023 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110338
9.
Prolonged Lenalidomide Induction Does Not Significantly Impair Stem Cell Collection in Multiple Myeloma Patients Mobilized With Cyclophosphamide or Plerixafor: A Report From The Covid Era.
Clin Lymphoma Myeloma Leuk
; 22(8): e716-e729, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35504807
10.
Therapy-related B-lymphoblastic leukemia after multiple myeloma.
Leuk Res Rep
; 18: 100358, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36353199
11.
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial.
Lancet Haematol
; 9(11): e822-e832, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36209764
12.
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma.
Cancer Cell
; 40(11): 1358-1373.e8, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379208
13.
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma.
Blood
; 114(4): 772-8, 2009 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-19471019
14.
Prospective Observational Study of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma: Microbiota Profiling and Cytokine Expression.
Front Oncol
; 11: 704722, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34249765
15.
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes.
Neuro Oncol
; 23(1): 112-121, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32750704
16.
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).
Blood Cancer J
; 11(5): 103, 2021 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039952
17.
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
J Hematol Oncol
; 14(1): 59, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849608
18.
Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma.
Br J Haematol
; 150(4): 428-37, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20618338
19.
Lenalidomide in myeloma--a high-maintenance friend.
N Engl J Med
; 366(19): 1836-8, 2012 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22571206
20.
Efficacy of aprepitant in patients receiving high-dose chemotherapy with hematopoietic stem cell support.
J Oncol Pharm Pract
; 16(1): 45-51, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19525301